$0.35
arrow_drop_up15.24%Key Stats | |
---|---|
Open | $0.30 |
Prev. Close | $0.30 |
EPS | -0.76 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $27.89M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.29 | 0.30 |
52 Week Range | 0.22 | 3.62 |
Ratios | |
---|---|
EPS | -0.76 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
Renalytix Announces Financing with Expected Size of up to $4 Million
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.